SPOTLIGHT: Study: Diabetics should take statins

For the second time this week, statins are being trumpeted for a new population. This time, it's diabetics who should be taking the cholesterol-lowering drugs; researchers found that deaths among diabetics fell by 9 percent with each statin-spawned step reduction in cholesterol. Report

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.